Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
104.00    -0.50 (-0.48%)
Bid:
103.50
Ask:
105.50
Spread: 2.00 (1.932%)
Market Cap: £303.92m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

AGM Statement

27 May 2022 07:00

RNS Number : 9787M
Big Technologies PLC
27 May 2022
 

27 May 2022

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

AGM Statement

 

Big Technologies plc, the UK-based, remote people monitoring technology company, will hold its first Annual General Meeting in London later today.

At the meeting, Simon Collins, Chairman of Big Technologies plc will make the following statement for the four months ended April 2022.

 

Following our initial public offering in July 2021, I am pleased to report that the team at Big Technologies has adjusted well to life as a listed business and we are confident in the future prospects for the Group. Our customers, suppliers, employees and shareholders have all benefitted from our listing, which brings increased disclosure, scale, financial strength and flexibility.

We have made good progress so far in 2022, continuing to increase the number of individuals that we track around the globe and expanding into new territiories. The pipeline of future opportunities remains strong and we expect to convert new customers to our products and services, steadily increasing our market share.

We continue to work hard to overcome the well documented global supply chain challenges and have increased our levels of inventory to secure certain long lead-time components. As we grow, the increasing cost efficiencies in our SaaS-like delivery model have enabled us to improve operating profit margins offsetting the inflation that we see in our manufacturing costs.

In the four months ending April 2022, we have recorded unaudited consolidated revenue of £13.9 million, an increase of 18% versus the same period in 2021. Monthly Recurring Revenue in April 2022 was £3.9 million and net cash as at 30 April 2022 increased to £52.6 million. These positive trends lead the Board to remain confident in the Group's ability to deliver results at least in line with current market expectations(1).

We believe that our products and technology deliver benefits for society across the globe. In the criminal justice sector our products facilitate a shift towards rehabilitative community-based sentencing which reduces recidivism and keeps communites safer. In the care sector our technology helps people live happier, healthier and more independent lives.

Our business has a clear strategy and strong values which underpin everything that we do. Our systems are trusted the world over to make a tangible difference to people's lives and we look forward to the next few years with confidence.

(1) Latest company compiled view of market expectations show adjusted EBITDA of £25.0 to £25.5 million (stated before share-based payments expense).

 

For further information please contact:

 

Big Technologies

+44 (0) 19 2360 1910

Sara Murray (Chief Executive Officer)

Daren Morris (Chief Financial Officer)

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Jamie Peel / Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEIFLMEESEDI
Date   Source Headline
4th Dec 202312:40 pmRNSEBT Share Purchase
20th Nov 202310:58 amRNSEBT Share Purchase
10th Nov 20239:08 amRNSDirector/PDMR Shareholding
8th Nov 20231:48 pmRNSEBT Share Purchase
1st Nov 20231:42 pmRNSEBT Share Purchase
25th Oct 202310:22 amRNSDirector/PDMR Shareholding
24th Oct 20234:57 pmRNSDirector/PDMR Shareholding - Replacement
24th Oct 202312:23 pmRNSDirector/PDMR Shareholding
24th Oct 202311:55 amRNSDirector/PDMR Shareholding - Replacement
23rd Oct 20235:05 pmRNSDirector/PDMR Shareholding
23rd Oct 20235:03 pmRNSEBT Share Purchase
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20239:05 amRNSIncrease in Share Capital
11th Oct 20231:40 pmRNSEBT Share Purchase
10th Oct 202311:40 amRNSEBT Share Purchase
3rd Oct 20237:00 amRNSEBT Share Purchase
28th Sep 20237:00 amRNSEBT Share Purchase
21st Sep 20237:00 amRNSEstablishment of an Employee Benefit Trust
19th Sep 20237:00 amRNSHalf-year Report
4th Aug 20238:57 amRNSStatement re legal claim
18th Jul 20237:00 amRNSIncrease in share capital and director dealing
7th Jun 20237:00 amRNSIncrease in share capital
23rd May 20231:43 pmRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
17th May 20232:10 pmRNSIncrease in Share Capital
26th Apr 20231:40 pmRNS2022 Annual Report and Notice of AGM
21st Apr 202310:27 amRNSDirector/PDMR Shareholding
5th Apr 20231:04 pmRNSDirector/PDMR Shareholding
4th Apr 202312:27 pmRNSDirector/PDMR Shareholding
31st Mar 202312:12 pmRNSIncrease in Share Capital
29th Mar 20237:00 amRNS2022 Preliminary audited results
23rd Mar 20231:01 pmRNSHolding(s) in Company
20th Jan 20237:00 amRNSTrading Statement
8th Dec 202212:38 pmRNSIncrease in share capital
18th Oct 20227:00 amRNSIncrease in share capital
20th Sep 20227:00 amRNSDirector/PDMR Shareholding
20th Sep 20227:00 amRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSHalf-year Report
14th Sep 20224:48 pmRNSHolding(s) in Company
13th Sep 20224:36 pmRNSPrice Monitoring Extension
6th Sep 20224:40 pmRNSSecond Price Monitoring Extn
6th Sep 20224:35 pmRNSPrice Monitoring Extension
26th Aug 20224:40 pmRNSSecond Price Monitoring Extn
26th Aug 20224:35 pmRNSPrice Monitoring Extension
1st Aug 20224:36 pmRNSPrice Monitoring Extension
1st Aug 20222:03 pmRNSDirector/PDMR Shareholding
1st Aug 202211:50 amRNSIncrease in share capital
25th Jul 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:19 pmRNSIncrease in share capital
16th Jun 20227:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.